Firefly Neuroscience, Inc.
AIFF
$3.20
-$0.01-0.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -78.31% | -84.55% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -78.31% | -84.55% | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -78.31% | -84.55% | -- | -- | -- |
| SG&A Expenses | 158.69% | 273.15% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 159.73% | 188.47% | -- | -- | -- |
| Operating Income | -198.25% | -243.33% | -- | -- | -- |
| Income Before Tax | -302.85% | -218.05% | -- | -- | -- |
| Income Tax Expenses | 100.00% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -302.77% | -218.10% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -302.77% | -218.10% | -- | -- | -- |
| EBIT | -198.25% | -243.33% | -- | -- | -- |
| EBITDA | -163.67% | -198.48% | -- | -- | -- |
| EPS Basic | -114.04% | -64.93% | -- | -- | -- |
| Normalized Basic EPS | -94.08% | -48.19% | -- | -- | -- |
| EPS Diluted | -114.04% | -64.93% | -- | -- | -- |
| Normalized Diluted EPS | -94.08% | -48.19% | -- | -- | -- |
| Average Basic Shares Outstanding | 90.46% | 85.61% | -- | -- | -- |
| Average Diluted Shares Outstanding | 90.46% | 85.61% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |